Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Mycoplasma synoviae 53, 53

>MS53_0502 conserved hypothetical protein
MPYFEVIKNLQTVIYTDNYNQKSLMNYLNKFNYSKNTIVSFYDYQNEKSN
NIVSIDKNKIKKYIEIWNLAKREDIFSKNKNILLFLSNKVLKLLNNTENE
KLENFFSFNKVKNNILKNQFCQVCHEFIEPLTNIFKDINLKYKEFNSSIK
NLENNFDYKLHLYNFWNILISANEELVKTYFKLYEKIESLIESYTSENNI
FLLKEQQKEVNKNKRKKEYLEYLQNNSPESLQNKINIKTKEYDLDFYSKY
KNDILISNYKYINFIKEKIKKEIAVLKIKRKLLLLKNREEILNIKIEILI
KKKIIKTFSYYKNKLNYLFESELASLHKQLNNEGNIFAAKNLIKKDKKHK
KQESLFYLNRLINYEFVLDINEYLEISENRKIQINEKLKNLEKDITNLKN
KIFSKYFPDNFKISKHNLEQDEEKTKAELQWLKDQNEKIATKLNANKQKD
FDEFLRYFRYTEKVLGVEKHIFENTSKKYNLFLDSKEKEFEKYIKEFNNN
FFSLFFVKELNNLFHNLKFPGFKITKDKLNIFFTTFKLNKLIKNNNFEYK
DLIDVFNSSNEDFLIKTKFLTSYIEGKKIIFIDLLEFSPEMNWNLYIEKI
QSYSELFKINTVLITSNLDILKNFGDQIHFFINNSFLEGGDKNEIFRRPI
NPIVKEILKGSNHKFEMLTNYKSWSANKMIDISTTKKHYIFSTITDFQKW
THQIVEHEDNSLKSFRKNKPENIKASSKEQLNIPSIFNDKTILLPKVKTN
ILNLEEPSEMVKELQEDLQSEMFFVEDELENNS
>MS53_0349 putative lipoprotein
MKRLTKKLIIPLVAVSTLPTLALVSCGRSDSENSTVSRLSLSSDVKDNQT
ITIRQKAYTASSNSVYTPVAFLTTGVNGFGVLDSDASSKKLKPLEVRVFS
SPTFETKVVRGENNTFTRSVKRSSFGTFAYKLGSAKKFIVTVFEDGQKVD
KVFDKDDYNAYSSARDDEREQQGYVHLLSDDVRSVNSPEFEKALKNAVHL
KIQVNTDISYVDNKGEIAKDKNGNAYKLQAKDFFLGYQHTFLDVNTTYRY
RNGGSSALDKAIFGTFNTATAGSINSFNEHLSNDVNRYLWDLYNIDANKI
LDEESFLTTDSDGNQYLNLYEKDSEENATSKKDATDFLTFFQYLNQSYDF
QPIPTKYIEDHSSDEKLFTPLTADKYQAFKSEYDKLSKDSLVYKTGQYWY
GYEPRNTLFLGQYLPEGFDSTSNQYITIKNKNYYDQSWVNNPQTFNYFVV
KYQNNPLDPQVYSDNSYNELTAGYLSSTSWHSLQSNQQSNILRNLDRYNL
SYLLNYNPLTLVTTTWWNLNPTKFSNDSSGVNPWANETASKLLYNVTNAE
VKGGDAVNLVKNSTSNYSNSFRSILQASVNWNEWVNTAWNTASLPWIATY
GMDARLDGKDADLQHPKTVRNEYYKNNSIFVVDKDGNKVTFTNLPQNRKG
FSEDNTYLGPLDSIQFSLTTDQRLKSVVFDQLKGEMKKLLDAFFQDNPTL
EQKVKITIPEPRAWTALVKNRIPDLKKVLNELDPRLDISWTEVPNPQYVS
NWYSNPNSLAEHIGWTYDYDGVTSGLNGFTTSRLGVDSMLFNLVADDQYK
TRMQKSFPMLVKVSEDFLKYLTDNKIVFRVKKDKNYEQKSLNEARAKEGF
DDLFLETSDTVTHKQVLTEYLKLPQKYLGIARDYLVKPSAKSPDLTFEVL
SSLFWLSEGRTLTMEELTKLGVELTTLLGTIPAFALFPVAQRFTAPESGL
PTEFAFVPNLYGRGVENATFKNGWSIKGNNADFLIKKEALK
>MS53_0371 conserved hypothetical protein
MKNSNKELNKIKFLQEGIKLTKNLIKNYKNSESKNSESNEKVLDLKNIKK
QKSKNFISKDSEIRYLAFGDSITAGFDASLPYDFESKLDEAGQITGISYP
ANLARLLNFNNKLKDFENFAISGSTIQDWLEFLENKNYSSERMQNELKEN
FDAKRNLFLAKLKNANLITLTLGANDFFFLITKKINKEDIALGPKFIYKL
FTEKNFGEIVNSLTEDIFPTIKSRLETLLEKVLEINPKANINVVSYPMPQ
IRLLEYTNEFWAKLFMDRIGQKPSNDFLDYLNNIIKSATLKFKEVNFVNI
YNEEYWENNLKNVSTFFVDIHPNLNGYKKMAMDLYLKITNPSFELKDYQN
YDYEFTKKFLLSDSDKVQYQIEKVADDKYLFGTSTNSYLQKFGDNEKEIA
SHIDFKNFGRRINEFSPLFNLFLSKIPQISVKNLSTEGFVSHLTQTFSYL
LQSYRQKNEKVIKILIKMNLLPEIFENVQLELESVLSKKPKDFSFFKILQ
IVRSNFFNEKNILLLLDHFTNNKFSLKEKEQFLISLSLFISNYLADQLDS
SFGLNLHIDEKNKLKKQGVFGSISDQLANLIFNNRDKFQDFSSFKKLLFE
IWMFDDFVTNKNLLNDFEKLFEKFVYSNNFYDKIKESAIEFVSKNNLSKK
EFLKSYQNIYRLFVTAFFKNKEDVDSRFFYLLDFVLKKSEFNLPNSFNYL
EEEFLNFISLNFESWDWNENINNLKTLIKEDEFFASNVVKLKNNFLNKLT
EKDLTESIFRFTKLIYGFSDILSDKKELKNNFGFIYKNKLFSEIAKSNFE
VLVQKIKENNKATNKQILKSIYSDFYKKYNKKILDLISNEISVEKLKNIF
FKTFETIAKASTNKAEIDLLKIKNISEKIFDFNSWIKELKDNLFEFFKNH
KDTIFKFDRKFLEYLYSFVEEKVKALLYFDLSKLNKNNDSEDFNELKDLQ
KSINDKLEKNQSKVEEQLRKVKEEIANFNSNFKKFKEGISKNEFDVDFLL
KSLENVSSLDADEIRNWALSNLNLDDKKVEQMLWYFDKDGFAELFKSFTK
DFKKNENKYKEFNDFYNLFKKFANENSEDNKVLNKLILWFKNNSKDFSKL
ISLFFFEYLKHIKINIKNIENNFNVISKFLSKYLDYLLSENKLNLKELFN
SKNLKNKFTFLENLFKEIMLNGKLNFFNLFFNFSKFVNKKNIKSIFEFLN
LTFENSYFNNENDFSGIYEQVSEFLKSKIDLNVFESNNYQILFNGVFKNI
FENYFQEVFKKNLDLDDEKWVNYYKSFFRIIVLFLWYVIKNFAKNHDDVI
KLLSEFSNLYNKAFSKLISSPKNNYTFANFNKKQELLLGYENGIFSLDFL
IGDTNIDLIKKKYFKNKNVFSLLYKAFDENKNFLKTNKNEKQLWNLLFEG
SLNKKEAFKHLDKLIKKY
>MS53_0442 conserved hypothetical protein
MLLQKYIKWNLVKYFNSISISLIGSEDFKLASSLYIFKITGSFWLVTILY
LLIQLPSIIIYSFSNKLIKILKDKNAHVLCDISSAIFLGIVFGISFWYLQ
EELFFVVLITLSTILGTIHAYRFIHLKNFYII
>MS53_0251 putative phase-variable hemagglutinin
MALHWDGFMPKIVVEGYVEDIEENNKNTNQQKLETWFKANQDKFTLVADQ
LTRKLGEEKFKNMTLSNPTISWDEVKFSNKVSNKGYLTPKVTFNLTPKED
YKKASDSSEKVTLTIRNLYKEANSDTNVFATQGAYYTATPSDNATTIEKV
NVYLNYTGPNIELDADLPTAGNKNNTSINGTSNVTGDFNNAFRGNPSKGL
LFTNRYANPLLKSVINYVNKFDPKYRATFVTDSRDGVTITKVENTKELRP
GTLDDLVKNRNKVFLQQIKGDKEAVYFAVTAIASNNWLNIFLIRIPLTKF
VRPLTEFQAQSPATPTQEASGDQAQASTPQTIPNSSQ
>MS53_0191 conserved hypothetical protein
MKEIVKPSLATADYVVIALYLTAVLGIGLFFFIQQIKRKKQNSVNNFFTG
EGKNPIWVVGFSIWATILSSNFFLAATGNAIATRWMWAGANISLVGITPF
IALFVVPFYRRLKESTAYSYLENRFNYATRVLASGLFIVFQIFRVAIVLY
VPTLAMTTVSDVNPEFILLGLGIVVILITMFGGFKAVVWTDALQGLILGM
GMVLVLFFALGKTNWSSSHVLLQKPLTIESWKVTLASGGIGFIFVYNIIN
SLYAFTSSQDVTQRYKGTKTIGEIRKTLYIAAGLGIFTVLIFFGAGAAIY
TYVSSQESVTVKELKEIAKNADGKLPANLVGLQDSDLVGQLAGQKTIGQI
DNVKAVPFFAKGGIEQGDKVFAYFVVKVLPQGVVGIIIAAVLAAAQSTIS
SGLSAVSNSIIVDFVDKTQWGKGLSAKYKANLSRLLVLLFGSVSLGGGLF
LLATKQQQIFNYITGTVGLLNAPVVGVFVLGVFTKRVNGKGSVAGIVLGF
LVAFPLWVFTQGFVPKELRIEFAGVWLTITSFLTAIITALVVSKLTGDAA
AMNKSIANKSYWTRTKEFKYLTELEENLEQVSKLVKKGKLSKEFETRYHA
VFEKMQHVVDAQ
>MS53_0186 putative oligopeptide ABC transporter ATP-binding protein OppF
MKKYYKETTNFKTTYRPIVEGLDTMLNAYPERDVLVQIRHLDIVYGSGFK
KFRAINDLSLNIYQGEVLGLVGESGSGKSTTGRAIVGLTPYQHGHIKLED
VVVPRKFSRGFKFGKKLQDYKKTLNYMANKVQMIFQDPANSLNPNKNIEK
VVSEGLDNLKNSRLIALATFDLAILKELSTKGYKKELCTFLKVAEKKYYS
TFESSHVFNKKTLYTDVRDYFAKANKPEYKELVKFLNDKSKEREKFEKMS
DKALKKHLIVDILKQVGLDKSVLSRYPLEFSGGQQQRIGISRSIVLRPKM
LVADEPISALDVSIQAQVVNIFNELKEKFNLTILFIAHDLRMVEYISDRI
AVIYKGTLLEVGPTHEVVKNPLHPYTKSLLDAVPSIESKKGSLIGFVYDP
SMHKYTKEVQPVWNDLGNKHYVFATKEEISAWKANKYDQLSTRKDAPKSE
FDVQTHSFGKDAKTKKPLSSSLLAKLKELKESLAKATKPAKAKPMQSKQS
QAKPLDPKAAAPAAKEAPKAKLEANLQDKSNKANSKSQLHSELNNTKTAK
DSVLEEFRNDSKVSSARTAQESRRSWNLDKLDKKK
>MS53_0338 putative aspartate-ammonia ligase
MDKELNFNTYKHQRQDLLLELETNLVKKLNLVKKTPPVKLSGNFGNENNY
VEFFVKDFSQYTSQLYKWNKISLKNFDKYEGLYNMPGPYYLNESGQYSYN
AKLLSWAQVIDYSDRNLVFLKKSANKVFLALKATEKFFVKKYSLSKKLGE
KVFLITTDMLYKQYPNLDASQREDEITKEHKVVFVYKIGYNLPDKKPHSE
KVFDDHDWKLNGDLFFYDEENKKAVKLASLGISVDEINLLKQKVYLKLSD
TTLDRYHHEVLARSLPYSISGEIFQDQLIELLLGTKQESNNGK
>MS53_0481 conserved hypothetical protein
MKYMRLYKRVKELLLPTQLIDKNLNIKLGFIMWSLLIFSYALFVVNWGFV
TGLNGQGGNDPGILSSFFKDGDKPSSFEVQATNWAITLGRGFGSILIGWM
IVKFTHKNSVVIALSLCLFAIPAPYMPSYALFVIFRTIFAIGGSTLMILF
QPLVTAYFKQKTKGMLSSFSTWGYPIGAIIVLVPFAFNIESAKVVRSHWQ
LILLISSSLYLIPLILYLILGQRFDLYRSYVISLKEKHLKELVAKGLNYQ
RPTIKMFLSKKSTYKWAIFYGSWLIAVTLPFVTIRDQLPNLVLQIYNHKD
VSIKEIRALALPIIALWLILFNGAIILAPYTVGLWNRLNARRKPFIITIL
LIGILLWIISILCFIFLVGPNLDKNAINKNIIPWSVSIPFLVLGFFAGLL
LWGIQGVFLNNPHEIPENTSEKIAMQFGFIWGFGYFFFTMLLIIISLLED
FTNHNLAPWLWFSLTIIFTIIAPITWYFISETKPDAPLIPKRKNQ
>MS53_0225 putative phase-variable hemagglutinin
MPKIVVPGYEADGEGNGKATHETTNQQKLQQWFATESNWEKLSEQLTKKL
GSDKFKNVTLTNPQVSYEEVTVGKYTWKNPKVTFNIQAKPGYQLTEPTTD
PKQISQTIRVLYENQASTQNLLTIQGASSSAAPSGSSVDDANVKANVNVY
LNYTGPNIELDADLPTVGGQENTSINGTSNVTGEFNTAFRGNPSKGLLFT
NRYANPLLKSVINYVNKFDPKYRAEFVTNSINGVTITKVQNTKELRPGTL
DDLNKNNVFLQQIQGDTKAVYFAVSAIASNKWLNTFLIRIPLTKFVRPIS
VFQATTAAPQDAAQTSEGQGSQPDQTA
>MS53_0155 conserved hypothetical protein
MKTKIHFVLEKYPLSQIFSLISYFLIFSVSLILLFMFPTIFKETNATAKQ
DADFSILFLYNNTEFQGLNFLLVFNYLYAFFTVLMTYFFAYRNSNKFLAP
SYKYIPYFLAYNLYALIVLIIAFVIKVDSPTMVFKKSFSFIGLLIINQIF
EIHDFRLNNYTKKEQALYAFNKTLKYITFAGLYAMFFIFTQETTYQSLFV
ENKLQNWMLANIFKNELASVMQLAAIILFVIVTVLSSFWAFLVRPNSLSQ
SKIFLKNVITVLIVISLAIALWYLVSIFLVADPNFKFVEIDPRSTMPAYE
VKFVDSYLVNQQINYYIFPAYIGTFFLLTLFVLVISNIKKVARENTRLIL
YSNVFAIALICAGAVGTNLYVEQKLTTTAVTIAMVVFVLAIVINWMFFTR
KPNFSQLLYIAAVLFLVGFIAAYQILSLNLSSIDNFSLATIAFRIKVPEI
AMILVTFISIVFMISKIAFWVFNTVNIYRYSKKYSQS
>MS53_0035 hypothetical protein
MWYFVIFKIKIMQNYKKNSTKMFYRIFFKKMSVPIAYSLIAIFIYYFFFT
LSYYYVSQQFSVQNFYERLKDENSFDSKWIFFWINLSFKFFRYEDFNFFV
LLFFYFLPILIWSYYLRLFYKSDYYKRIILLNGNKKTFRYIGLYLVIFWF
LIFLIINLVSLKPIDYLYKYLAWKEGGDGNYKNYVKWIPWLNPFILYDSK
FKGENFPYNEFKIGETNFFYLENKFYTHIFLMFLSFFTAIAFVSVSFYIN
KWILYLIYFLTLVSLILDSSKILMVFFPYDEAYQYIGSELKFKKFLVKIP
FSFFNPYSLLDVFASFHFLSKKITINWLFPVILISIFNFSVLAFSAWTMR
RNFKYSFL
>MS53_0262 putative phase-variable hemagglutinin
MKTSGSVTKAKEAKDDAEYSKVTDTLKTTLEEKYTAATALLEDGTKLKNL
DADGTLATTQASLESAKTALDAAVSTLMPELTFVKTKASAVKTASELGPL
VNEALLAELRKQANDLPKNDQSKADKLDSELKSLKESLESLQTLVSDGLK
MQVDYPQKYYDADNKEAFDAALLKASSVFPAFQWTEDSIVVPAPIDGALP
NPRAWTKARDKSEFKLQNFVISPAQAAAPTTAQTSPSAAATATVRVAMSE
EAAAEAETQTPAAPMADLASTASYLKTLETELKTQSEALNGETPATKTAY
YKADTTRTLYWDGFMPKIVVDGYVADGAGANKAQHETANRPLLQQWFEAN
QDKLSLVADQLTKKLGSDKFKNVTLTNPVVTYEEITVNSNTWKNPKVTFN
IQAKPGYQLTEPTTEESQISLSIRVLYENQTSTQNLLTIQEASPSAAPRR
ATVNDENVKSKVNVYLNYTGPSIVLDADLPTVGEQENTSINGTSNVEGTF
NTKFKNLLVNVVGESITQTSLLQAIINYVNKFDPKFPAEFVLKTNGVTVA
SVQNNTQLRIGSLNDFLWNNKGFLQQVNGDSSAVYFAVNGVTSEGWLNTF
LIRIPLTKFVRPISVLEEQTTEEETQESQEGQENQEQGSTTQTNTESSGT
GQSSDLTEVSA
>MS53_0239 putative phase-variable hemagglutinin
MYWDGFMPKIVVPGYQADGAGANKAQHETANRPLLQQWFEANQDKLSLVA
DQLTKKLGSDKFKNVTLTNPVVTYEEITVNSNTWKNPKVTFNIQAKPGYQ
LTEPTTEESQISLSIRVLYENQTSTQNLLTIQGAYPFAAPRNATVNDENV
KSKVNVYLNYTGPSIVLDADLPTVGGQENTSINGTSNVTGDFNNAFRGNP
SSGLLFTNRYANPLLKSVINYVNKFDPKYRATFVTDSRDGVTITKVENTK
ELRPGTLDDLLSNKNKVFLQQIKGDKEAVYFAVTAIASNNWLNTFLIRIP
LTKFVRPLTEFQAQSEAAPTEETSGEQDSAPTGTGS
>MS53_0263 putative phase-variable hemagglutinin
MIQKYKPNLGLIINKIYWDGFMPKIVVPGYEADTTGRNKDTNEAANLEKL
KTWFDTPANWEKLAEQLTKKLGSDKFKNVTLTNPQVSYEEVTVNSNTWKN
PKVTFTVEAKPGYELTQPTTDSKQISLTIRVLYSSQESNQNLLTIQGASP
VAAPNTASADNPASAIKNVNVYLNYINQFKLTN
>MS53_0423 putative amino acid permease
MKVKTARKIGLLIATSISISSVIGIGIFFKNFTVLGAQTVPETDTFAFWS
FILAWVLGAFISLLTVYSFSELSSSRQSKSGLAGWVEELSGSKKQGMTVK
FLHSGFYYALLTAALPVFGMEAIFKAFEVATGSSVSQEPEFYLVVILLSL
VFLVAMTALNYFSLKWSSRLQVFSTAFKLLPLAIAFILGFVGTKYLGVDP
KATDSASLEIVNKANEAKSYYLFGGLSYGITSGEKSFNFVGMFIALPAVL
FAFDSFLSVGNLAKDVKNPKTVPVAAVLTIVISATVYILISIGAALKGTG
FVGNLFTDIVLSVSKDPATRLTASKVLNSFVFFLIGFGALFVANSTSIVL
LKSSEGLIESRQVMFYKKLGELNKRYKNLGSLVLYSVFVSIYLLVVVLPS
AISLSDSVIDSSTNLPTIMFFFIYAYTMLLGIIDRFKGGKKTKLKVKGFL
PASVLSILLIVAVIGFQFVYKFIVKTTQSPNVADSAGLFFSGTTVFTLAH
NSLTNFGLLALCIILALTNYFVVKKQLKSEGLTIQDTGNASDSEEEISYE
ETSHEKHEGIFCKMMHKFKPKK
>MS53_0190 putative lipoprotein
MKYSLGLALSSLMAPAIAISCASNASKEPTPLLSNNKKLDYDLGLSAPSL
NSLNYVLYKSVDLIVPSLVDTVYKFGPVSELQAILGKTPLTFGVYGNNNN
SVSLEKYVNSPDLENNNYQSDRSYPFDNFGIDVGAGSFQALSARGGRGLF
TPNARVITYTITLNDGRSRWSNGDVQTVDDFLDYIHYIADINTGSQKQID
LLSRDIKGLDQFVSLQNEYLKKFGTTYKNPWGYPPYEKVNGKWQYKVDAR
DENGNQLSNKDYLWPSQNEGDEQDVEKIQQAALNVGFWSGRLFFNISNKD
LYNLLKLKDNKDVDPSNGDTITLKDKDGNDLVLRRNPYIDPRQVFQYARI
DSSNFQSYEDARLIGKYIIFARDEHEFRVEYAESNPKSIDDMINDLNRNW
LPINRAFVENELGGIQNFGKDKRSILINGPFLIDSLILGSQGSLTLAKNQ
SYFNVNRTISNKIKIYFNDERNLESAMFSDGYIAFAKIPSVLQKKFWADP
EFRNLMSKTTGYGTLGFMFNLDQETNKDSYINDPDLRNAFYYAINREVML
FNSGWNNSYPVITWTGFGNAHKSDGTAIEFGFQDQWTTPKGSYATDQKVP
LQNYSYGDHLSKNYKFEATNRTDQGYRPEVAKHYMEVFKAKHPGLKQVNL
TYIFNSTEEQRNVGLVLKNSLELLFGNFINLELKALPENVYISKVEEGDF
DIAYKNFDSFGTEIDSYVKAFFVEDGINRENSKTTGFNLNPSGGFTYKKY
FDSLADSKDLVNGSLVAKTEEETRERLGVSQEIWNKIKELSQRRDDEDEF
QYKDRYSNFFSYQFTDKEKTQGYDENKVIEIVAGLEKIIRDAAPVIPLME
VDTLWNISRVGGTRNLFRYDLQYAYDIDRPPVPGLPRVTAGQSS
>MS53_0482 putative amino acid permease
MISKNKKYLSAKYFAFFTINFVVGFGFIATIFNVLEKKVYGFVVLAAASF
IAFGVLLVFSRLSDTYKETYGGSYAYSKDLMYEIDSKGNRVLGTKKSHQV
YKHLTFFTGWTQFIQGPILSATSPIFLVAILEPFFRNSDGTSNEVTINII
RGVSFLVYIILILITTFGLRINRWVVLAAASVKWLILLFSLILGVYLISQ
GNIYSSNLTLTKSDEEKISFYLVISSVLTFMYAYGGIEGVSAISKDVKAK
SFRKILMYSFVFIFVFYVVFYLILLGIKTEYNGQKIDQIRNIFSAVWGLS
GAVFFAVGIFFQQVSSKISGTVTIARSVAPMAEDKFLPVSLAKTNSKNEF
KNAIWFSTAITIFSLVIFYVIPLVLKANGYEEPSSYLSQVVNIGTIPFLV
QYLLTFIIAFILEHKKRITKIPLWEKIIYVLASIAIIVVLAVYIFPVIAN
ERWSASNTITLVSYSGFTLLGYVFYFATRKYYKNKKLKNN
>MS53_0134 conserved hypothetical protein
MKNKFKFLILFSTLPLSASLISCSSNIQDTKKDYLDQNFQVPINNENQTE
LAAILSLDKNDSLENSSIYKNDQDYFRNFFNTYDKNFQSLLETVNESKKK
EIAETLMSEITKNWYYVFNNLLLFQPYFYKWFNLPDTKEAKHSPFYKDQT
LVSHKHIAIPRFTTYQNGKVLENFTDYNIDKNEIHFYLLLSQNTFARFLG
KKDPNSEKFNFEVKLFTTTNNAQKINLQEIYNDIETNLKTPNQKSYEDFE
IKYSRSGKYGYLAELVLKPSLI
>MS53_0288 conserved hypothetical protein
MIVALGDSITAGFDWTFPDDFPGKLENNQITGSSYPAFLAKIFNKQNRIA
SFNNYAKSGATISQWLKLFDINYPGQNDASLNIFGNSPQEIKDFQTKVLS
DLKKQI
>MS53_0305 glyA, Serine hydroxymethyltransferase
MYKNLKLNDKYVQKAINSEFKRQRNFIELIASENYVSDDVLKAQGSVLTN
KYGEGYPYRRYYGSCENVDMVEQVAIDRLKEIFKVNYANVQPYSGSVANA
AAIASVVPNGGKIMGLSLKSGGHLTHGYKISFSGIFYNSITYEVGKNGKL
DYEEIKKIALAEKPDLIICGYSAYPRLIDFKKFREIADLCGAKLMADVAH
IAGLIAGGVHPSPVGYAHVITSTTHKTFRGARGGVIMTNDEEIAKKVDRW
VFPGYQGGPLFHAIAGKAIAFYEALQPSFKTYAENIVKNAKVFSEAFIKK
GVEVVSGGTDNHLLLINVKSSYNITGKEAENFLEKINITINKNSIPFDEL
PPLVTSGIRLGTAAMTSRNFTKWEELAEIIDYSLRNLEFLNSKSKAARDK
VKELKNRVLSFNKEFPILKKY
>MS53_0198 nanA, acylneuraminate lyase
MFPAMVTPFTKDGKLHKAGVKEVVNFLVEKQKVDGIYITGSTGEFLLLSF
EDKKEVMKLVAEANAGRVTLIAQIGSLNIEETKELAKLAKELKYDAISAI
TPYYYNFSFNETHHYYEEISKAADIPMLIYYLPQLAGQKVSTDQFGKLLE
IKNVIGSKYGATDLFAFERLMSKYPDKLFMFAWDEALAMGLTMGAKGFIG
STYNVNAKGANAIIKAWEANDKEAVMKLTHTYNDYVLDLISKGLMQSLKA
IMRLHGVDAGYTRKPFWRYEDEEIKKHAEFITDKYLK
>MS53_0322 nifS, nitrogen fixation protein NifS
MMKKNLRANFPILKDIIYFDNSALVLKPLSAINALRDFYLKYSISSRTSD
TPIGVLVNSQIQSVREKVASLLDAKVSEIIFTSGTTESINYFVDMYGHNF
SEKDLIIVSGYNHAANLLPWINLSKKNKFKLIITENITREILKHQDKISL
ISLSVENNNFQSKEDYEFIVNYCKKYNVILVNDAAQSISHQKTSLNEYDV
IAFSFNKFYGPTGMGVLALKEKLIKKLSLSKFGGGSLAEVKKNKDFNFKN
NLTLFEPGTPNIANFFMADKSLDFFNEIGYEQTQEILNDLSLYLHEKLTE
VKNLVIYSSPGDNIALINFKNIPAQDVSDYLGSKNIYTIAGIFCSQYLRN
IQSQYSFVRISLGIYNNKKDIDKLISELKNVEGNYGIW
>MS53_0184 oppB, putative Oligopeptide transport system permease protein
MKAGLKACFLTKETQMKETKLKKPSSSSVMLEKIVPNYVTLDNRSLDEKK
WYVKLFNVESPLLKSTWRFTKIILEFFTIAFIVITITFFLINSVPGDTGV
ESGLSEAQKVAVRQQLGLDLPLFNRYLNYIRDLFRGDFGVSLSVFPRTSI
NDFIFDRLITSLYVGLWSVCLTVMIGVPIGVIVGKRPDGILDNITTVIIS
ILSSVPSLIFAILLLILGKNLNIPYIFDVNNFATYILPGFALSLGSIIVY
IKYIKTELNRELNSMHSKFCYLKGLSRSRFVWTHALKPSLFPIATFFPAV
VLGSFVGSIFIERIFTITGSGNILFSAITSKDYNIILFQVVFFSLLTILS
YTIRDILYELIDPRIRRKGGR
>MS53_0348 oppB-1, oligopeptide ABC transporter permease protein
MIKYLTQRVLLAIFTIFAIAIIVFFLVAYFAENPFVKEWENSGFKAEQAE
SVFQRSKDTYLIKPDTEFSRFEPLAWIDKKESVFVRFGYWVKSVFDSNQP
FGFVFNQNILSNADVKTIPAYFFRFLPYSLIITLPSFLISASLGIFLGII
AGYKRGKFFDWIVNLLSQFFVALPIFVTASVVILVLLSVFGTPPLFLLPR
DIEINGLSNTIASWASPIFVVVIGSLAGYITFVRNQVVTVLTSNYVLIAK
SKGLNQRQIFFKYVLRNISIPLAATLIPSYIGLLSGGVVIETYWRVPGVS
NVIVNAFPNGEINIIMFSTVFFTTLSVFTTIIVDISFVFLDPRIRYYSSS
TSLLFLFKQYLVRNKEKKLAQAKN
>MS53_0185 oppC, oligopeptide transport system permease protein
MSNKDAPNPLLKPFAYQQWKMVGNILEYRESAYLKTSLSPFKQFLNRYSK
SWSGVFGFVFLVAIFLFTFLFPLIWNDTSASNDAKDGYLQPFFKGHFLGT
TSRGNDFWTLIWHGLRYSLLLSLVVTLVEVFIGVTFGILMGHFEWFDKAF
TFFIKIFSVIPTIIILILVTIVINPTFWVIALALSLTGWTGMANQIRAQV
KRAKNFEWISASKVLATPTYKILLSYLPVIVPILVTQLVFTIPGVILSET
SLAFIGLSIPDAITLGTLINEGINTFSIYPRYVLIPASFLIVITTSVQLI
GSAIQTSLLKQR
>MS53_0347 oppC-1, oligopeptide transport system permease protein
MKLSSKEFNKKYNLNEKMLQNSLVRHVPKANLQFNNAAGKPKKLLNEILK
RYFSTWFFSLALVVFLAVLIFSIVISLTSKYSSSTSINNTSGLTYTLLDG
KTQIGTSNRTASLPPVFNPFVNLTLGSSGISQQVYNNSVTLWNSDSYFHG
LVYKTVFNPDNTSVRLEDGNLYVNAYSFYKADSISIILAQSQQRGLIAKD
LTQDQVLSYIEEIKRLNPQINLSTYLGTNSAGVDVWTSSWVGTWNAIRLA
VIVSFIQTMIGVFIGAYLGFHAGSLLDTIAMRIISIITSPPTLIWLLIAS
SIFGTSDLTLAITLIVVGWPGSVGITRLYIITVKDSDFIQASRLVGASKI
RLILRHALPAIVGKIANSFVASIPSIILSVSALAFLGFFKGNTANLGSIL
SSAPSEAGTNIWILVLPVGILLSISLSLQFIALGVHDSLDPKVIRGK
>MS53_0187 oppD, oligopeptide ABC transporter ATP-binding protein OppD
MMNKEFKGYSKLYDKPLKHENKNTYHELKDSFTHHKKVSKWKQVENNYKS
FLEKLRFAKKEFRIQDFIKNAKTEKVFGKDTVVAAEIEDIHLSFLNPANP
KEKNVVLRGTSLKIYEGYVHAIIGESGSGKSVITSLLYGLTGNNAVIDFG
KIKLFNNEVQDFTFTDWENRKIRGTIVSAVFQNPMSILDPTMKVGKQITE
GLLINKVVKTKMEAKKVALEYLKMTKINNPEKIMNAYPHELSGGMIQRIA
IASVMSLKPKILVMDEPTTALDPTVQALVLDIVREFQEKLKIAIVFITHD
LGVVASISDFISIMYAGQIVETGTKEEILEHPQHPYSWGLIMSMPDFNNS
EKLTTIRGSVPSSLNNIKGDAFAVRNDYALGVDLEVEPAMYQISDTHYVK
SALLDEKAPKYELPPLIKKMWQKYHQKLKELHQ
>MS53_0346 oppD-1, oligopeptide ABC transporter, ATP-binding protein
MVMNTKKQLLKARNLKVSFKLKKKNFLNIVRGVDLDIYPGEIVGLVGESG
SGKSVTSKALLSINENAFMSAKELWIDDINLLNLNKESKWVKIRGQKIGY
IPQDPLTSLNPTRKIGKQLLDSLNQNSEWKTKPLAEKKEYLIGLLKKFGI
RNAEQVFEMYPHLLSGGMKQRIVITMIVALKPLLIVADEPTTALDPTVQA
SVLKLFEDICREMKISIILISHNISVIAKVCDYIYVMYAGKIVEKGLKEE
IFTDPKHPYTWALISAIPENKEQRLYSIKGTPPDMSNLPVGDAFAPRNEY
ALEIDFLKEPPLFEVTKTHMLHHDYFTLIHQK
>MS53_0345 oppF-1, oligopeptide ABC transporter ATP-binding protein
MKAKAQENSKKILEISNLKKYFLNKNSVNKAVDNVSFSVYEGEIVGLIGE
SGSGKTSVARTITRFYENYNGFVTLDSKIISGNKISKKRLKHMRRNMQMI
FQDPMASVNGQNNVYSILKEPLVVNGVIQEKVKRVLKSWKQVKKNYFYTF
LELAKKLELKDKALINSLFEPFYTKWSNKFQELTDEDLNLEDLYNSFVAY
LEEKNKIYSELTNNLYSLSNQLIEKFEEKVKAFEEDKMDADKTRLKLALD
NYNKEKKLNRKNKAYFASLDTFKNTFKEFKDSFTNKKETKAIGKSILDSL
LSEVKNEAKLAKNSALSSANLKEYDFYIHLNQVYKFLYKLVKSNYAKLMY
FDFETGKTFRDNLLNYATTYFVSKSSDSSSWTNEKFKENFKFSLDEYLNN
SQKNKKQIDKDFAQNVKTFKSSLKKTFKNFFLKPDKNPEKLAKAKKNYEE
AQQNFDKELAKYIEKFELKIQRIKEKIKHQDSLSDSLKKVEKDLDSKFKE
LNAKYVELYKKQRILPLETKKNKTPSEARSLKNAKVELSAQESLVKERLK
SSKAFNLEQKYLNIDIDNINLLLGISKLDVFIKKHPYLEALNWLLYPYKV
LKIRALYIKSTIYKALEDVGLLKQFAYRYPHEFSGGQLQRIVIARALIIN
PKIIVADEPIASLDISIQAQIVNLLKDLCKKKNIGIIFIAHDLSMVEYIA
DKVQIMHLGKIVESGKTEKVYTSPLHPYTNTLFQSIPKISNANEKFQEIS
FDTKYLEEQKFPNATFLKEVEDNHYLFGTESQINKWSKKLKNVKKT
>MS53_0154 pepA, leucyl aminopeptidase
MKIQYNQKNESDIVINFVFYDSKKIKDFIIKKNGYLTEDLENKIAYLYID
EKHANIDGLTKVIDSFASSIKRNYQINTESLTSHFDIYDALRILIMRLDF
HSSVLFKKSIDDLKEVKKFKPQISLIINTFDEKHVDNYVKKIKIISNSVK
SARFLQSMPENFLNSEQLAHYVAKDLKQIPEIQVTVFTKSNIEHLGMNLL
LSVNKGSTHEPRVVILEYNGDPESKQKTVFVGKGITFDTGGVNTKGYHTE
GMKYDMSGSVVAAFALKALAKLKAKVNAAAIMCITDNRSAGDASLPENVY
QSMSKKWVEVVDTDAEGRLVLADGIFYSASVLKATTIVDIATLTGSLKFA
LGETYSGVWSTSDEKWEKLKEASLTTFEKIWRMPLHEDYHKENKNSKVAD
LKNYSSKVPCDHNQAAMFLKEFTKGVDFIHCDIAYTAAKDQVAQGVLIPT
LVEFALNLKS
>MS53_0153 pepA-1, leucyl aminopeptidase
MKLNKVTNQRNSDMLLKAVFDSEKTKECKLLLKKQNQVTEFFSENTAKAY
LGSEEKYTYETLVKFVKQFVSSQARPYQVDVASFAKKAVKPRHVVKAFVD
AYNYANADLYSAKTNQKNSDEEKALSLLFVSNNPGEVSELELIYRKQTVL
SEAVNFARNLQILPPNIANSEYLAKKVENELSEYANLEVKVLDKEQIEDL
NMGLLLSVNRGSMYEPRVVVIEYNGNKESEEKTVMVGKGITFDSGGYSLK
PARSMLGMKFDMSGAAIVASVMMAVAEFKPKVNLSAVLCLTDNRVNGDAS
LPDSVWESMSGKTVEVNNTDAEGRLVMADGLTYAVRKLNATRLIDVATLT
GAILSALGTTYTGVWATSDQDWQSVLMASKVQDELVWRMPLDDEFSKEIK
KSLVADLKNTDLTGMGGSNSAAMFLKEFTENRKYVHFDIAGTAEQSGNPT
GVMVKTLVQLAINESIREMKK
>MS53_0350 pepF, oligoendopeptidase F
MKTKRFENRSSIPKKYKWDLDSILDGKSLQKHIDDYQKLFSRRIKAKDLK
FENLEAFIEDLKTLEKLLIVTNKISNYISNNLNANLVSEEIKKAANEFDF
LSKKLESEFGSEYNRLYKHKAKLKKWYLDPKLSFYRHSLDVLLESFKYKL
HDEVEEYIVKSSHGTISLESIFTTITDSEVVFEPALDSKHKKHVLNTANK
NELLKSNDSALRKDVYHKYLKGYLKHKESLALILFDHFKAITVEAKTRNY
KNTISMLLSEDKVDEKLLELLFEKTQKATKGSFVKYKQNLKKFYLAKFNS
KMQPWDSQRELLKLKNKYSIEEAQKLALSSLKPFGKEYTEKIKEAFREKW
IDYMPCKNKITGAYSIGASFGLDKKYILMNYNYSLDSVFTLVHELGHSMH
SYYSDKKQNIFNASYPIILAEIGSIYNELMLFDYLYENSKSKKEKFYLLQ
KFIDNFIDTVIKQTMWANYEFDLYSKIESGVAVNSFEYLSEIYYQNLVKY
SMSKSKPKKDEKLNISSVTIPHFYYYFYVYKYAIGQLVGINFYLQYKKGK
SSVIKNYIENFLSMGGSDFPLEILQKVGLNLYSEEFYKNGFDFIDSLIQK
WIKLGNSIFKK
>MS53_0149 pepP, XAA-PRO aminopeptidase
MDKTRLLKLLDLHKADALVSEALQTRLWYAKVETSDGYIVVEKDKATLFV
DNRYIEYAKKTAKNVEVKLLAGDNLKNFFKEKRFKKVLLEENYLTKQLTK
HLLSLMDLKEENVAWVHGQELRVVKSKEEVETLQEVVDLSLKSYDQLMAW
LRSKLDKKEKVTEKHAAAKLAYFMQINGCSKEGFDSIVATGKNAAEPHHH
PTDDVIEDNEILKVDFGGLYKGFCADITRTSFLGDRAKAKDPKVLEVLQI
VEEAAKAGRDAVRPGVLASDIDLVCRNYIKAKGYENYFLHSTGHGLGIDV
HELPVVSFRGETVLEPGMVITVEPGIYLEGLTGARIEDDVLVTETGRRVL
SRKDEN
>MS53_0508 potA, spermidine/putrescine ABC transporter ATP-binding protein
MNIGGFFLQNNTTKSVKNNNVIELIDIVKQFDEKLVLDNVNLNIKRGEFV
TLLGPSGSGKTTILRLIGGFEWATRGEIKFNGVDIKDLSPHKRNLSTIFQ
DYALFPHLNVEGNIMYGLKLKRVPKENVKKEHKNLLERKIKVWTEKAQRE
MKNLDKLQEEYENELKVLKPGTYKHQKRQTWLDDSDFKYSYWESYVLQKT
EEFKNKYFKRKLTKEEIDQTVDKIVNLVGLQNNKNKKITELSGGMKQRVA
LARSLIIEPEILLLDEPLSALDAKIREKMQVFLKQIQQELKLTFIFVTHD
QDEALELSDRIAVIREGKIEQYDTPKQIYDYPRNIWVAKFIGNSNIFNAK
FLKDSKVELLNKEFKTIHDEDEFAVDEEVDALIRPEDIDIVNQTQNTEHK
IKGKIVESIYRGSYYYIKVELKDSNYIFVETAKNFAVDETVYLSWTIDSI
HLMKKDPKWDYAKKDF
>MS53_0509 potB, spermidine/putrescine ABC transporter permease protein PotB
MLLIPFFVIAILLILLPIVLILVNSIAPRNNFDNWLLVKESNTWNIILRS
LKLGFIASIICLFIGIIYAYWVSKSKNKFFKIYALTLIISPLAIFTIARI
YSIKGLFLALFAGDPKSLNSEWFIVVGLVYLNLPLMIMPLYSVFKDMPKN
TVEASNDLGYSNFKTFFKVIIPYATKAILSGIAMIFLASATTFVVARKLL
PDGSQNQLIGELINEKINPGNPFDLSSGSALVIVVSAIFIGTYLLILIVP
KVIYHFKKGAVYE
>MS53_0510 potC, spermidine/putrescine transport system permease PotC
MSDFSNWKTILRSSYIYVILLAVYIPLFFGLVFSFNQETPKGEFNTTWTK
GTFENWRNLFDFGRDASAVNSFLLAFIVGFINVFLSLITVYALYRQKNKL
AKPAVLSNSNIPLVNPDNITAIGLVLVFGLFFGITATDSEGFFRVIVGHV
VMVIPYGISLSLPRSYKFNNNLFEASQDLGYSKLRSWFKTYFVYMLPSIL
MTFVVSFVFSIDDFIIARTVSNTSTLGTKLYEGAFQAWGLILGSIVLIIT
LVGNVIYTIINARKKK
>MS53_0150 prsA, ribose-phosphate pyrophosphokinase
MDNSNIILFGMDNCKVLAEEISKILNIKLTPIVKTTYQDGETMLVSENTV
RNRDVYIIASTSKNVNHSYMELFLFLDSLKRASAKNVTVALTYYGYARQD
RKVSGRQPIGAKLMANLLQKAGADRIISIDLHNPSIQGFFDIPVDDLKAQ
YPLALELKKTYSNNFTIVSPDHGGTVRARKFAELISDNLKICIIDKRRTG
ANQSEVMGILGEIKNQNAVIVDDIIDTGGTILKAAKALKNEGAKDVILVA
SHGLFTKGFEIFENDENIKEVLITNSVDNYENLSKFKKLKIVSLASFLSE
VISASVVGESISEIYKKWKEAITLFNNGIQK